[Frequency of recurrence following treatment of hyperthyroidism with methimazole and suppressibility of the thyroid gland (author's transl)].
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000032:analysis; D008134:Long-Term Care; D008297:Male; D008713:Methimazole / Q000627:therapeutic use*; D051379:Mice; D011379:Prognosis; D012008:Recurrence; D014284:Triiodothyronine / Q000097:blood
D000906:Antibodies; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D008713:Methimazole; D008135:Long-Acting Thyroid Stimulator
Rezidivhäufigkeit methimazolbehandelter Hyperthyreosen und Suppressibilität der Schilddrüse.